Core Laboratories Cash Flow Statement
CLB / Energy|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
Core Laboratories generated $37M in operating cash flow and $26M in free cash flow in FY2025. Free cash flow margin was 4.9% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | $29.7M | $31.4M | $36.7M | $19.5M | $19.7M |
| Depreciation & Amortization | $14.6M | $15.0M | $15.8M | $17.2M | $18.5M |
| Operating Cash Flow | $37.0M | $56.4M | $24.8M | $25.0M | $36.6M |
| Capital Expenditures | $11.2M | $11.9M | $10.6M | $10.2M | $13.5M |
| Free Cash Flow | $25.8M | $44.5M | $14.2M | $14.7M | $23.0M |
| Share Buybacks | $12.4M | $5.3M | $2.2M | $3.9M | $8.3M |
| Dividends Paid | $1.9M | $1.9M | $1.9M | $1.9M | $1.8M |
| FCF Margin | 4.9% | 8.5% | 2.8% | 3.0% | 4.9% |